Tracers / [86Y]pepa-pic2
[86Y]pepa-pic2
- Radionuclide
- Y-86 t½ 884.4 min
- Modality
- Therapy
- Production route
- —
- Stage
- Reported once
- Syntheses indexed
- 1
What it is
- Compound class
- pepa-pic2 chelator platform (rare-earth chelator)
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| Manual synthesis | — | none | — | — | pepa-pic2 | 41324598 2025 J Am Chem Soc Optimization of radiolabeling conditions was conducted using 86YCl3 at pH 5.5, to yield [86Y]Y-mepa-pic2, [86Y]Y-pepa-pic2, and [86Y]Y-pepa2-pic |
Need this precursor?We can point you to suppliers for [86Y]pepa-pic2, or handle the enquiry for you.
Get in touchNotes
Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 41324598. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 41324598: '[86Y]Y-pepa-pic2'.